Prostate cancer stem cells, telomerase biology, epigenetic modifiers, and molecular systemic therapy for the androgen-independent lethal phenotype (Q82744393)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 March 2006

Language	Label	Description	Also known as
English	Prostate cancer stem cells, telomerase biology, epigenetic modifiers, and molecular systemic therapy for the androgen-independent lethal phenotype	scientific article published on 01 March 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16520275%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

1 reference

Europe PubMed Central

Prostate cancer stem cells, telomerase biology, epigenetic modifiers, and molecular systemic therapy for the androgen-independent lethal phenotype (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16520275%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

neoplastic stem cells

1 reference

based on heuristic

inferred from title

systemic therapy

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Kenneth S Koeneman

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16520275%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 March 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16520275%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Urologic Oncology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16520275%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

24

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16520275%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16520275%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

119-121

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16520275%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

TGF-{beta} maintains dormancy of prostatic stem cells in the proximal region of ducts

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Sca-1 expression identifies stem cells in the proximal region of prostatic ducts with high capacity to reconstitute prostatic tissue.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Proximal location of mouse prostate epithelial stem cells: a model of prostatic homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Cell-autonomous induction of functional tumor suppressor 15-lipoxygenase 2 (15-LOX2) contributes to replicative senescence of human prostate progenitor cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

CD133, a novel marker for human prostatic epithelial stem cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Hedgehog signalling in prostate regeneration, neoplasia and metastasis

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Evidence of pluripotent human prostate stem cells in a human prostate primary xenograft model

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Telomerase activity, telomere length, and DNA ploidy in prostatic intraepithelial neoplasia (PIN)

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Histone deacetylase inhibitors suppress telomerase reverse transcriptase mRNA expression in prostate cancer cells.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Androgen ablation therapy for prostate carcinoma suppresses the immunoreactive telomerase subunit hTERT.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Telomerase as a new target for the treatment of hormone-refractory prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

The Shortest Telomere, Not Average Telomere Length, Is Critical for Cell Viability and Chromosome Stability

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Cellular and gene expression responses involved in the rapid growth inhibition of human cancer cells by RNA interference-mediated depletion of telomerase RNA.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Recent advances in telomere biology: implications for human cancer.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

The signals and pathways activating cellular senescence

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Epigenetic changes in prostate cancer: implication for diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Histone acetylation-independent effect of histone deacetylase inhibitors on Akt through the reshuffling of protein phosphatase 1 complexes

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

The development of differentiation agents for the treatment of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

In vivo and in vitro antitumor activity of butyroyloxymethyl-diethyl phosphate (AN-7), a histone deacetylase inhibitor, in human prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Depsipeptide (FR901228) enhances the cytotoxic activity of TRAIL by redistributing TRAIL receptor to membrane lipid rafts

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Chemical ablation of androgen receptor in prostate cancer cells by the histone deacetylase inhibitor LAQ824.

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLONC.2005.11.031

7 January 2021

Identifiers

10.1016/J.UROLONC.2005.11.031

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16520275%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16520275%20AND%20SRC:MED&resulttype=core&format=json

17 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q82744393&oldid=1710338775"